Active Ingredient History

  • Now
Lexatumumab is an experimental agonistic human monoclonal antibody against TRAIL-R2, intended for the treatment of cancer.   Wikipedia

More Chemistry
etr2-st01 | hgs1018 | hgs-etr2 | lexatumumab


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue